Orchid Pharma Limited - Asset Resilience Ratio

Latest as of March 2026: 4.03%

Orchid Pharma Limited (ORCHPHARMA) has an Asset Resilience Ratio of 4.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Orchid Pharma Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs770.66 Million

≈ $8.33 Million USD Cash + Short-term Investments

Total Assets

Rs19.11 Billion

≈ $206.66 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2026)

This chart shows how Orchid Pharma Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Orchid Pharma Limited's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Orchid Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Orchid Pharma Limited total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs770.66 Million	4.03%
Total Liquid Assets	Rs770.66 Million	4.03%

Asset Resilience Insights

Limited Liquidity: Orchid Pharma Limited maintains only 4.03% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Orchid Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Orchid Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Orchid Pharma Limited (2004–2026)

The table below shows the annual Asset Resilience Ratio data for Orchid Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	4.03%	Rs770.66 Million ≈ $8.33 Million	Rs19.11 Billion ≈ $206.66 Million	-5.17pp
2025-03-31	9.21%	Rs1.55 Billion ≈ $16.81 Million	Rs16.88 Billion ≈ $182.54 Million	+9.15pp
2024-03-31	0.06%	Rs9.23 Million ≈ $99.81K	Rs15.54 Billion ≈ $168.05 Million	-0.27pp
2023-03-31	0.33%	Rs40.15 Million ≈ $434.16K	Rs12.25 Billion ≈ $132.50 Million	+0.33pp
2022-03-31	0.00%	Rs59.00K ≈ $638.06	Rs11.11 Billion ≈ $120.10 Million	-1.28pp
2021-03-31	1.28%	Rs158.21 Million ≈ $1.71 Million	Rs12.37 Billion ≈ $133.80 Million	+1.28pp
2020-03-31	0.00%	Rs122.00K ≈ $1.32K	Rs14.60 Billion ≈ $157.88 Million	-7.58pp
2019-03-31	7.58%	Rs2.33 Billion ≈ $25.22 Million	Rs30.77 Billion ≈ $332.77 Million	-1.07pp
2018-03-31	8.65%	Rs2.70 Billion ≈ $29.25 Million	Rs31.25 Billion ≈ $338.00 Million	+1.39pp
2017-03-31	7.26%	Rs2.36 Billion ≈ $25.57 Million	Rs32.56 Billion ≈ $352.08 Million	+7.28pp
2016-03-31	-0.02%	Rs-6.73 Million ≈ $-72.80K	Rs38.62 Billion ≈ $417.67 Million	-0.44pp
2011-03-31	0.42%	Rs171.78 Million ≈ $1.86 Million	Rs40.71 Billion ≈ $440.21 Million	-5.03pp
2010-03-31	5.45%	Rs2.06 Billion ≈ $22.25 Million	Rs37.74 Billion ≈ $408.10 Million	+3.04pp
2009-03-31	2.41%	Rs1.02 Billion ≈ $11.04 Million	Rs42.34 Billion ≈ $457.89 Million	-0.61pp
2008-03-31	3.02%	Rs1.05 Billion ≈ $11.36 Million	Rs34.84 Billion ≈ $376.81 Million	-1.09pp
2007-03-31	4.10%	Rs1.19 Billion ≈ $12.83 Million	Rs28.91 Billion ≈ $312.65 Million	-0.26pp
2006-03-31	4.36%	Rs945.99 Million ≈ $10.23 Million	Rs21.69 Billion ≈ $234.52 Million	+0.73pp
2005-03-31	3.64%	Rs659.20 Million ≈ $7.13 Million	Rs18.12 Billion ≈ $196.01 Million	+2.74pp
2004-03-31	0.90%	Rs128.15 Million ≈ $1.39 Million	Rs14.28 Billion ≈ $154.41 Million	--

pp = percentage points

About Orchid Pharma Limited

NSE:ORCHPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$542.04 Million

Rs50.12 Billion INR

Market Cap Rank

#11836 Global

#589 in India

Share Price

Rs988.20

Change (1 day)

-1.48%

52-Week Range

Rs482.45 - Rs1101.40

All Time High

Rs2527.90